Post-approval studies (Phase 4)Study completedNCT03497689
What this trial is testing
EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 36